ANI PHARMACEUTICALS, INC (ANIP) Operating cash flow 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$185.2MFY2025 · since FY2016: $27.5M → $185.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $185.2M | +189.3% |
| FY2024 | $64.0M | -46.2% |
| FY2023 | $119.0M | +481.2% |
| FY2022 | -$31.2M | -1039.3% |
| FY2021 | $3.3M | -78.2% |
| FY2020 | $15.3M | -66.5% |
| FY2019 | $45.6M | -32.0% |
| FY2018 | $67.1M | +70.2% |
| FY2017 | $39.4M | +43.5% |
| FY2016 | $27.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Net marginANIP Gross profitANIP Gross marginANIP Operating incomeANIP Operating marginANIP Free cash flowANIP Capital expendituresANIP Return on equityANIP Stock buybacksANIP Dividends paidANIP Total assetsANIP Total liabilitiesANIP Shareholders’ equityANIP overview →